News

Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage algorithm – a CE-marked IVD ...
The American Bazaar15h
Swiss pharma giant Roche to invest over $50 billion in the US
Roche CEO Thomas Schinecker said in a statement on Tuesday that the company’s new $50 billion investment demonstrated its ...
GlobalData on MSN21h
Roche announces $50bn US investment in pharma and diagnostics
Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...
GlobalData on MSN8d
Roche’s Columvi combo gains EC approval for DLBCL
Roche continues to explore Columvi as both a single agent and with other medicines for the treatment of mantle cell lymphoma ...
F. Hoffmann-La Roche Ltd: Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage algorithm - a CE-marked IVD medical device1 set to transform cardiac careThis novel algorithm offers a s ...